Heart Retransplantation to Treat a Case of Refractory Cardiac Allograft Vasculopathy / 대한내과학회지
Korean Journal of Medicine
; : 287-291, 2016.
Article
em En
| WPRIM
| ID: wpr-20331
Biblioteca responsável:
WPRO
ABSTRACT
Cardiac allograft vasculopathy is one of the most important causes of poor long-term survival after heart transplantation. The condition tends to be diffuse, usually affecting the mid-to-distal portions of the coronary artery. Reperfusion therapy is ineffective. Everolimus, an inhibitor of proliferation signaling, has been reported to prevent development of the condition; however, the efficacy thereof has not yet been fully accepted. The only definitive treatment for cardiac allograft vasculopathy is retransplantation. Herein, we describe the case of a 15-year-old boy who underwent heart retransplantation because of rapidly progressive cardiac allograft vasculopathy.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Reperfusão
/
Transplante de Coração
/
Vasos Coronários
/
Aloenxertos
/
Everolimo
/
Coração
Limite:
Adolescent
/
Humans
/
Male
Idioma:
En
Revista:
Korean Journal of Medicine
Ano de publicação:
2016
Tipo de documento:
Article